Targeting NF-kappaB-inducing kinase shapes B-cell homeostasis in myasthenia gravis
Abstract Background B cell immune dysregulation plays a critical role in myasthenia gravis (MG). However, targeted B-cell therapy such as rituximab may result in long-term peripheral B cell clearance and allow for the survival of plasma cells, contributing to frequent infections and relapses. Theref...
Saved in:
Main Authors: | Xiaoyu Huang, Zhouao Zhang, Zhouyi Wang, Tiancheng Luo, Mingjin Yang, Xinyan Guo, Xue Du, Tianyu Ma, Yong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12974-025-03342-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rituximab in Refractory Myasthenia Gravis – Challenges and Lessons Learnt
by: Karthika A Valaparambil, et al.
Published: (2024-12-01) -
Multiple Brain Abscesses in a Patient with Myasthenia Gravis – a Case Report
by: S. Radzevičiūtė, et al.
Published: (2023-12-01) -
Exploring the clinical significance of anti-acetylcholine receptor antibody titers, changes, and change rates in Myasthenia Gravis
by: Lijun Luo, et al.
Published: (2025-01-01) -
The Association Between Myasthenia Gravis and Higher Extrathymic Cancer Risk
by: Mohamed Khateb, et al.
Published: (2025-01-01) -
Surgical Treatment of the Oroantral Fistula in a Patient with Myasthenia Gravis: Clinical Considerations and Anesthetical Management
by: Elif Betül Yıldırım, et al.
Published: (2024-04-01)